Study of Angiocal® in Patients With Solid Tumors, Investigating Safety, Tolerability, Blood Concentration of Study Drug

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01141257
Recruitment Status : Completed
First Posted : June 10, 2010
Last Update Posted : October 19, 2011
FGK Clinical Research GmbH
Information provided by (Responsible Party):
Pieris Pharmaceuticals GmbH

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2011
  Actual Study Completion Date : September 2011